Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016-17

Sandra Jackson; Teresa C.T. Peret; Thedi T. Ziegler; Natalie J. Thornburg; Terry Besselaar; Shobha Broor; Ian Barr; Elsa Baumeister; Mandeep Chadha; Malinee Chittaganpitch; Badarch Darmaa; Joanna Ellis; Rodrigo Fasce; Belinda Herring; Kadjo Herve; Siddhivinayak Hirve; Yan Li; Maria Pisareva; Ann Moen; Amel Naguib; Rakhee Palekar; Varsha Potdar; Marilda Siqueira; Florette Treurnicht; Almiro Tivane; Marietjie Venter; Niteen Wairagkar; Maria Zambon; Wenqing Zhang

doi:10.1111/irv.12771

Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016-17

Sandra Jackson, Teresa C.T. Peret, Thedi T. Ziegler, Natalie J. Thornburg, Terry Besselaar, Shobha Broor, Ian Barr, Elsa Baumeister, Mandeep Chadha, Malinee Chittaganpitch, Badarch Darmaa, Joanna Ellis, Rodrigo Fasce, Belinda Herring, Kadjo Herve, Siddhivinayak Hirve, Yan Li, Maria Pisareva, Ann Moen, Amel NaguibRakhee Palekar, Varsha Potdar, Marilda Siqueira, Florette Treurnicht, Almiro Tivane, Marietjie Venter, Niteen Wairagkar, Maria Zambon, Wenqing Zhang^*

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

7 Citations (Scopus)

Abstract

Background: External quality assessments (EQAs) for the molecular detection of respiratory syncytial virus (RSV) are necessary to ensure the provision of reliable and accurate results. One of the objectives of the pilot of the World Health Organization (WHO) Global RSV Surveillance, 2016-2017, was to evaluate and standardize RSV molecular tests used by participating countries. This paper describes the first WHO RSV EQA for the molecular detection of RSV. Methods: The WHO implemented the pilot of Global RSV Surveillance based on the WHO Global Influenza Surveillance and Response System (GISRS) from 2016 to 2018 in 14 countries. To ensure standardization of tests, 13 participating laboratories were required to complete a 12 panel RSV EQA prepared and distributed by the Centers for Disease Control and Prevention (CDC), USA. The 14th laboratory joined the pilot late and participated in a separate EQA. Laboratories evaluated a RSV rRT-PCR assay developed by CDC and compared where applicable, other Laboratory Developed Tests (LDTs) or commercial assays already in use at their laboratories. Results: Laboratories performed well using the CDC RSV rRT-PCR in comparison with LDTs and commercial assays. Using the CDC assay, 11 of 13 laboratories reported correct results. Two laboratories each reported one false-positive finding. Of the laboratories using LDTs or commercial assays, results as assessed by Ct values were 100% correct for 1/5 (20%). With corrective actions, all laboratories achieved satisfactory outputs. Conclusions: These findings indicate that reliable results can be expected from this pilot. Continued participation in EQAs for the molecular detection of RSV is recommended.

Original language	English
Pages (from-to)	671-677
Number of pages	7
Journal	Influenza and other Respiratory Viruses
Volume	14
Issue number	6
DOIs	https://doi.org/10.1111/irv.12771
Publication status	Published - 1 Nov 2020

Bibliographical note

Funding Information:
The WHO Global RSV Surveillance pilot project was supported by an award made to the World Health Organization by the Bill and Melinda Gates Foundation (grant no. OPP1127419) with additional support from the Respiratory Viruses Branch, Division of Viral Diseases, CDC, Atlanta, and the CDC International Reagent Resource (IRR), USA. The authors would like to thank Brett L. Whitaker and Senthil Kumar K. Sakthivel (Respiratory Viruses Branch) for the technical help during the development, manufacturing, and shipping of the CDC RSV 2016 EQA panel.

Funding Information:
The WHO Global RSV Surveillance pilot was supported by an award made to the World Health Organization by the Bill and Melinda Gates Foundation (grant no. OPP1127419). The WHO Global RSV Surveillance pilot project was supported by an award made to the World Health Organization by the Bill and Melinda Gates Foundation (grant no. OPP1127419) with additional support from the Respiratory Viruses Branch, Division of Viral Diseases, CDC, Atlanta, and the CDC International Reagent Resource (IRR), USA. The authors would like to thank Brett L. Whitaker and Senthil Kumar K. Sakthivel (Respiratory Viruses Branch) for the technical help during the development, manufacturing, and shipping of the CDC RSV 2016 EQA panel. We are grateful to the national and international experts who participated in the informal consultations in March 2015, February 2016, and June 2016 that led to the strategy for development of the WHO RSV EQA. We acknowledge National Influenza Centres, Public Health Laboratories, and the Ministries of Health of pilot countries for participating in the WHO RSV EQA 2016. We thank colleagues in the Global Influenza Program, Influenza Preparedness and Response, Dept. of Infectious Hazards Management of the WHO Health Emergencies for supporting this work.

Funding Information:
The WHO Global RSV Surveillance pilot was supported by an award made to the World Health Organization by the Bill and Melinda Gates Foundation (grant no. OPP1127419).

Publisher Copyright:
© 2020 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.

Keywords

RSV external quality assessment
polymerase chain reaction
respiratory syncytial viruses

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1111/irv.12771

Cite this

Jackson, S., Peret, T. C. T., Ziegler, T. T., Thornburg, N. J., Besselaar, T., Broor, S., Barr, I., Baumeister, E., Chadha, M., Chittaganpitch, M., Darmaa, B., Ellis, J., Fasce, R., Herring, B., Herve, K., Hirve, S., Li, Y., Pisareva, M., Moen, A., ... Zhang, W. (2020). Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016-17. Influenza and other Respiratory Viruses, 14(6), 671-677. https://doi.org/10.1111/irv.12771

@article{00d71b998d274114baba96d2ee007c26,

title = "Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016-17",

abstract = "Background: External quality assessments (EQAs) for the molecular detection of respiratory syncytial virus (RSV) are necessary to ensure the provision of reliable and accurate results. One of the objectives of the pilot of the World Health Organization (WHO) Global RSV Surveillance, 2016-2017, was to evaluate and standardize RSV molecular tests used by participating countries. This paper describes the first WHO RSV EQA for the molecular detection of RSV. Methods: The WHO implemented the pilot of Global RSV Surveillance based on the WHO Global Influenza Surveillance and Response System (GISRS) from 2016 to 2018 in 14 countries. To ensure standardization of tests, 13 participating laboratories were required to complete a 12 panel RSV EQA prepared and distributed by the Centers for Disease Control and Prevention (CDC), USA. The 14th laboratory joined the pilot late and participated in a separate EQA. Laboratories evaluated a RSV rRT-PCR assay developed by CDC and compared where applicable, other Laboratory Developed Tests (LDTs) or commercial assays already in use at their laboratories. Results: Laboratories performed well using the CDC RSV rRT-PCR in comparison with LDTs and commercial assays. Using the CDC assay, 11 of 13 laboratories reported correct results. Two laboratories each reported one false-positive finding. Of the laboratories using LDTs or commercial assays, results as assessed by Ct values were 100% correct for 1/5 (20%). With corrective actions, all laboratories achieved satisfactory outputs. Conclusions: These findings indicate that reliable results can be expected from this pilot. Continued participation in EQAs for the molecular detection of RSV is recommended.",

keywords = "RSV external quality assessment, polymerase chain reaction, respiratory syncytial viruses",

author = "Sandra Jackson and Peret, {Teresa C.T.} and Ziegler, {Thedi T.} and Thornburg, {Natalie J.} and Terry Besselaar and Shobha Broor and Ian Barr and Elsa Baumeister and Mandeep Chadha and Malinee Chittaganpitch and Badarch Darmaa and Joanna Ellis and Rodrigo Fasce and Belinda Herring and Kadjo Herve and Siddhivinayak Hirve and Yan Li and Maria Pisareva and Ann Moen and Amel Naguib and Rakhee Palekar and Varsha Potdar and Marilda Siqueira and Florette Treurnicht and Almiro Tivane and Marietjie Venter and Niteen Wairagkar and Maria Zambon and Wenqing Zhang",

note = "Funding Information: The WHO Global RSV Surveillance pilot project was supported by an award made to the World Health Organization by the Bill and Melinda Gates Foundation (grant no. OPP1127419) with additional support from the Respiratory Viruses Branch, Division of Viral Diseases, CDC, Atlanta, and the CDC International Reagent Resource (IRR), USA. The authors would like to thank Brett L. Whitaker and Senthil Kumar K. Sakthivel (Respiratory Viruses Branch) for the technical help during the development, manufacturing, and shipping of the CDC RSV 2016 EQA panel. Funding Information: The WHO Global RSV Surveillance pilot was supported by an award made to the World Health Organization by the Bill and Melinda Gates Foundation (grant no. OPP1127419). The WHO Global RSV Surveillance pilot project was supported by an award made to the World Health Organization by the Bill and Melinda Gates Foundation (grant no. OPP1127419) with additional support from the Respiratory Viruses Branch, Division of Viral Diseases, CDC, Atlanta, and the CDC International Reagent Resource (IRR), USA. The authors would like to thank Brett L. Whitaker and Senthil Kumar K. Sakthivel (Respiratory Viruses Branch) for the technical help during the development, manufacturing, and shipping of the CDC RSV 2016 EQA panel. We are grateful to the national and international experts who participated in the informal consultations in March 2015, February 2016, and June 2016 that led to the strategy for development of the WHO RSV EQA. We acknowledge National Influenza Centres, Public Health Laboratories, and the Ministries of Health of pilot countries for participating in the WHO RSV EQA 2016. We thank colleagues in the Global Influenza Program, Influenza Preparedness and Response, Dept. of Infectious Hazards Management of the WHO Health Emergencies for supporting this work. Funding Information: The WHO Global RSV Surveillance pilot was supported by an award made to the World Health Organization by the Bill and Melinda Gates Foundation (grant no. OPP1127419). Publisher Copyright: {\textcopyright} 2020 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.",

year = "2020",

month = nov,

day = "1",

doi = "10.1111/irv.12771",

language = "English",

volume = "14",

pages = "671--677",

journal = "Influenza and other Respiratory Viruses",

issn = "1750-2640",

publisher = "Wiley Open Access",

number = "6",

}

Jackson, S, Peret, TCT, Ziegler, TT, Thornburg, NJ, Besselaar, T, Broor, S, Barr, I, Baumeister, E, Chadha, M, Chittaganpitch, M, Darmaa, B, Ellis, J, Fasce, R, Herring, B, Herve, K, Hirve, S, Li, Y, Pisareva, M, Moen, A, Naguib, A, Palekar, R, Potdar, V, Siqueira, M, Treurnicht, F, Tivane, A, Venter, M, Wairagkar, N, Zambon, M & Zhang, W 2020, 'Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016-17', Influenza and other Respiratory Viruses, vol. 14, no. 6, pp. 671-677. https://doi.org/10.1111/irv.12771

TY - JOUR

T1 - Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016-17

AU - Jackson, Sandra

AU - Peret, Teresa C.T.

AU - Ziegler, Thedi T.

AU - Thornburg, Natalie J.

AU - Besselaar, Terry

AU - Broor, Shobha

AU - Barr, Ian

AU - Baumeister, Elsa

AU - Chadha, Mandeep

AU - Chittaganpitch, Malinee

AU - Darmaa, Badarch

AU - Ellis, Joanna

AU - Fasce, Rodrigo

AU - Herring, Belinda

AU - Herve, Kadjo

AU - Hirve, Siddhivinayak

AU - Li, Yan

AU - Pisareva, Maria

AU - Moen, Ann

AU - Naguib, Amel

AU - Palekar, Rakhee

AU - Potdar, Varsha

AU - Siqueira, Marilda

AU - Treurnicht, Florette

AU - Tivane, Almiro

AU - Venter, Marietjie

AU - Wairagkar, Niteen

AU - Zambon, Maria

AU - Zhang, Wenqing

N1 - Funding Information: The WHO Global RSV Surveillance pilot project was supported by an award made to the World Health Organization by the Bill and Melinda Gates Foundation (grant no. OPP1127419) with additional support from the Respiratory Viruses Branch, Division of Viral Diseases, CDC, Atlanta, and the CDC International Reagent Resource (IRR), USA. The authors would like to thank Brett L. Whitaker and Senthil Kumar K. Sakthivel (Respiratory Viruses Branch) for the technical help during the development, manufacturing, and shipping of the CDC RSV 2016 EQA panel. Funding Information: The WHO Global RSV Surveillance pilot was supported by an award made to the World Health Organization by the Bill and Melinda Gates Foundation (grant no. OPP1127419). The WHO Global RSV Surveillance pilot project was supported by an award made to the World Health Organization by the Bill and Melinda Gates Foundation (grant no. OPP1127419) with additional support from the Respiratory Viruses Branch, Division of Viral Diseases, CDC, Atlanta, and the CDC International Reagent Resource (IRR), USA. The authors would like to thank Brett L. Whitaker and Senthil Kumar K. Sakthivel (Respiratory Viruses Branch) for the technical help during the development, manufacturing, and shipping of the CDC RSV 2016 EQA panel. We are grateful to the national and international experts who participated in the informal consultations in March 2015, February 2016, and June 2016 that led to the strategy for development of the WHO RSV EQA. We acknowledge National Influenza Centres, Public Health Laboratories, and the Ministries of Health of pilot countries for participating in the WHO RSV EQA 2016. We thank colleagues in the Global Influenza Program, Influenza Preparedness and Response, Dept. of Infectious Hazards Management of the WHO Health Emergencies for supporting this work. Funding Information: The WHO Global RSV Surveillance pilot was supported by an award made to the World Health Organization by the Bill and Melinda Gates Foundation (grant no. OPP1127419). Publisher Copyright: © 2020 The Authors. Influenza and Other Respiratory Viruses Published by John Wiley & Sons Ltd.

PY - 2020/11/1

Y1 - 2020/11/1

N2 - Background: External quality assessments (EQAs) for the molecular detection of respiratory syncytial virus (RSV) are necessary to ensure the provision of reliable and accurate results. One of the objectives of the pilot of the World Health Organization (WHO) Global RSV Surveillance, 2016-2017, was to evaluate and standardize RSV molecular tests used by participating countries. This paper describes the first WHO RSV EQA for the molecular detection of RSV. Methods: The WHO implemented the pilot of Global RSV Surveillance based on the WHO Global Influenza Surveillance and Response System (GISRS) from 2016 to 2018 in 14 countries. To ensure standardization of tests, 13 participating laboratories were required to complete a 12 panel RSV EQA prepared and distributed by the Centers for Disease Control and Prevention (CDC), USA. The 14th laboratory joined the pilot late and participated in a separate EQA. Laboratories evaluated a RSV rRT-PCR assay developed by CDC and compared where applicable, other Laboratory Developed Tests (LDTs) or commercial assays already in use at their laboratories. Results: Laboratories performed well using the CDC RSV rRT-PCR in comparison with LDTs and commercial assays. Using the CDC assay, 11 of 13 laboratories reported correct results. Two laboratories each reported one false-positive finding. Of the laboratories using LDTs or commercial assays, results as assessed by Ct values were 100% correct for 1/5 (20%). With corrective actions, all laboratories achieved satisfactory outputs. Conclusions: These findings indicate that reliable results can be expected from this pilot. Continued participation in EQAs for the molecular detection of RSV is recommended.

AB - Background: External quality assessments (EQAs) for the molecular detection of respiratory syncytial virus (RSV) are necessary to ensure the provision of reliable and accurate results. One of the objectives of the pilot of the World Health Organization (WHO) Global RSV Surveillance, 2016-2017, was to evaluate and standardize RSV molecular tests used by participating countries. This paper describes the first WHO RSV EQA for the molecular detection of RSV. Methods: The WHO implemented the pilot of Global RSV Surveillance based on the WHO Global Influenza Surveillance and Response System (GISRS) from 2016 to 2018 in 14 countries. To ensure standardization of tests, 13 participating laboratories were required to complete a 12 panel RSV EQA prepared and distributed by the Centers for Disease Control and Prevention (CDC), USA. The 14th laboratory joined the pilot late and participated in a separate EQA. Laboratories evaluated a RSV rRT-PCR assay developed by CDC and compared where applicable, other Laboratory Developed Tests (LDTs) or commercial assays already in use at their laboratories. Results: Laboratories performed well using the CDC RSV rRT-PCR in comparison with LDTs and commercial assays. Using the CDC assay, 11 of 13 laboratories reported correct results. Two laboratories each reported one false-positive finding. Of the laboratories using LDTs or commercial assays, results as assessed by Ct values were 100% correct for 1/5 (20%). With corrective actions, all laboratories achieved satisfactory outputs. Conclusions: These findings indicate that reliable results can be expected from this pilot. Continued participation in EQAs for the molecular detection of RSV is recommended.

KW - RSV external quality assessment

KW - polymerase chain reaction

KW - respiratory syncytial viruses

UR - http://www.scopus.com/inward/record.url?scp=85088781252&partnerID=8YFLogxK

U2 - 10.1111/irv.12771

DO - 10.1111/irv.12771

M3 - Article

C2 - 32730685

AN - SCOPUS:85088781252

SN - 1750-2640

VL - 14

SP - 671

EP - 677

JO - Influenza and other Respiratory Viruses

JF - Influenza and other Respiratory Viruses

IS - 6

ER -

Results from the WHO external quality assessment for the respiratory syncytial virus pilot, 2016-17

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this